111 results
8-K
EX-99.1
BAX
Baxter International Inc.
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
and other key stakeholders in the areas of governance, strategy, risk management, and metrics and targets. Moving forward, Baxter expects to report against
8-K
EX-10.1
nzujo
3 Oct 23
Baxter Appoints Joel Grade Chief Financial Officer
9:07am
8-K
jrfab6udo2unldwv3
3 Oct 23
Baxter Appoints Joel Grade Chief Financial Officer
9:07am
8-K
EX-99.1
0b9tcielhp4dxh8ixja8
6 Jul 23
Regulation FD Disclosure
8:30am
8-K
EX-2.1
intu vaxh
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-99.1
vggw2aw2ohu1ir6qv
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm
424B3
zmo8sj8lq vw
12 May 22
Prospectus supplement
8:58am
8-K
EX-99.1
3sb9jp5mv
13 Dec 21
Creating ~$15 Billion Global Medtech Leader
4:46pm
8-K
EX-99.2
sfioia78 dq
13 Dec 21
Creating ~$15 Billion Global Medtech Leader
4:46pm
8-K
vglnf lrv4i2kt
13 Dec 21
Creating ~$15 Billion Global Medtech Leader
4:46pm
8-K
yocy imh5lepq6
2 Dec 21
Entry into a Material Definitive Agreement
4:31pm